71 publications
| Name | Date | Type | Actions |
|---|---|---|---|
ANNUAL RESULTS 2023 (slideshow) 01.2023 Highlights |
Annual Report | ||
2023 ANNUAL RESULTS Annual sales: €529m (stable at constant exchange rates) |
Public releases | ||
Monthly information regarding the total number of voting rights – February 2024 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
Voting rights | ||
Monthly information regarding the total number of voting rights – January 2024 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »
|
Voting rights | ||
Buyback programs – January 2024 Monthly communication regarding buyback programs |
Description of buyback programs | ||
Annual sales 2023: €529 million Annual Sales of Essential products: €313 million (up 4.5% at constant exchange rates) |
Public releases | ||
Monthly information regarding the total number of voting rights – December 2023 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
Voting rights | ||
2024 Calendar of financial communication Vetoquinol published its calendar of financial communication for 2024. |
Agenda | ||
2020 calendar of financial communication December 16, 2019 (Lure, France) - Vetoquinol published its calendar of financial communication for 2020. |
Agenda | ||
Vetoquinol and Klox Technologies Announce Global Animal Health Collaboration Agreement December 12, 2019 (Lure, France) - Vetoquinol S.A. and Klox Technologies Limited, a subsidiary of Klox Technologies Inc., have entered into an exclusive global licensing agreement, excluding the People’s Republic of China. |
Public releases |